BrightInsight offers a global regulated digital health platform for biopharma and medtech.
BrightInsight provides a digital health platform for bio-pharma and med-tech. Its IoT platform is built under a quality management system to support and optimize regulated drugs, devices, and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement. BrightInsight was founded in 2017 and is headquartered in San Jose, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 30, 2021 | Series C | $101M | 2 | General Catalyst | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
General Catalyst | Yes | Series C |
Gaingels | — | Series C |